Explore Stanford technologies available for licensing:

Stanford researchers have discovered that tumors increase the risk of atherosclerosis by regulating expression of a specific gene that stimulates angiogenesis and intraplaque neovessel formation.

Stanford scientists have discovered that treating colonized kidney stones with a cationic biopolymer effectively disrupts bacterial biofilms and reduces bacterial burden while remaining biocompatible with kidney tissue.

Stanford scientists have discovered a series of compounds that inhibit PTER and leads to weight loss. They found that inhibition of PTER, a key enzyme that regulates N-acetyltaurine metabolism, leads to N-acetyltaurine accumulation and a reduction in food intake.

Stanford researchers have developed a method to overcome the packaging capacity limitation of adeno-associated virus (AAV) Vector CRISPR/Cas9 systems to help treat genetic diseases for which the cargo is larger than 4.7kb.

Stanford researchers have produced 5 varieties of Gold Bantum, a one hundred year old public sweet corn variety, which have new colors and gloss, including:

Stanford researchers at the Ferrara Lab have designed an ultra-fast standing device for breast ultrasound which is more comfortable than current designs and has higher resolution.

Stanford researchers at the Ferrara Lab have developed a method to select receptor targets for molecular imaging and therapies by applying spatial transcriptomics, proteomics, and machine learning.

This technology includes a set of machine learning methods designed to extract meaningful information from immune cell receptor protein sequences.

Stanford researchers have developed Miro1 Reducer, a small molecule that targets the mitochondrial protein Miro1 to treat Glioblastoma, addressing the root cause of tumor growth and immune resistance, and demonstrating significant efficacy in reducing tumor size and improving

Quantum scientists in the LINQS, Schuster, and Simon Labs at Stanford have developed a method of multiplexing many low-light optical fields onto a single fast sensor.

In many diseases, such as cancers and neurodegenerative disorders, the mislocalization of proteins can disrupt cellular functions and drive disease progression. Traditional therapeutic approaches often fail to address these specific localization issues.

Stanford researchers have developed kirigami-inspired electronics (KiriE), flexible electronics that transition in suspension from a flat 2D pattern to a 3D basket-like configuration to seamlessly integrate with and chronically record electrical activity from 3D neural organoi

Stanford scientists have identified tuberculosis (TB) epitopes preferentially recognized by T cells in patients who naturally resist or control TB infection. Targeting these epitopes for vaccine development could lead to effective vaccines for TB.

Stanford researchers have developed a targeted therapy for Alzheimer's disease that focuses on inhibiting the spread of tau protein, a key factor in disease progression.

Stanford researchers have developed a genetic strategy using antisense oligonucleotides (ASO) to reduce the levels of PCDH19 in human forebrain neurons, as a therapeutic approach for PCDH19-related encephalopathy.